Developing a valid patient-reported outcome measure
- PMID: 21975345
- PMCID: PMC3753201
- DOI: 10.1038/clpt.2011.195
Developing a valid patient-reported outcome measure
Abstract
Many aspects of patients’ experiences with illness, medication, and health care are best captured from patient-reported outcomes (PROs). In this article, we describe the process for constructing quality PRO instruments, from conceptual model development through instrument validation. We also discuss PROs as clinical trial end points and the potential of PRO data for aiding clinicians and patients in choosing from among multiple therapeutic options. Finally, we provide an overview of some existing PRO instruments.
Conflict of interest statement
The authors declared no conflict of interest.
Figures
References
-
- US Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. 2009 < http://purl.access.gpo.gov/GPO/LPS113413>.
-
- Willke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials. 2004;25:535–552. - PubMed
-
- Sloan JA, et al. National Cancer Institute. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007;25:5070–5077. - PubMed
-
- Lohr KN. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205. - PubMed
-
- Earp JA, Ennett ST. Conceptual models for health education research and practice. Health Educ Res. 1991;6:163–171. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous